Skip to main content
OpenTrials
Completed

NCT Number: NCT04417946

Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)

The aim of this study is to examine the effect of social media intervention on the use of pre-exposure prophylaxis (PrEP) by young men who have sex with men (YMSM) in the greater New Haven area.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pre-exposure Prophylaxis Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Endocrine Gland Neoplasms Endocrine System Diseases Genetic Diseases, Inborn Genital Diseases HIV HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Men Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia Type 1 Neoplasms Neoplasms by Site Neoplasms, Multiple Primary Neoplastic Syndromes, Hereditary RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

18 year–29 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

APNH: A Place to Nourish your Health (APNH), New Haven, Connecticut, United States

Loading trial locations.

About this study

There are three specific aims of this study. In the first specific aim, two focus group discussions (FGDs) of YMSM will be conducted to assess the feasibility and acceptability of social media intervention. In the second specific aim of the study, a quasi-pre-post experimental study will be conducted to examine the effect of social media intervention on PrEP uptake (primary outcome) and PrEP use intention, HIV testing, PrEP knowledge, self-efficacy and social support (secondary outcome). In the third specific aim of the study, the most important topics around PrEP will be assessed on the Facebook page of the intervention group by conducting a content analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Biologically male or transgender man
  • Self-identification as gay or bi-sexual
  • Resident of greater New Haven area
  • Willing and able to use Facebook during the span of the study

Exclusion criteria

  • • Women will not be included in the study
  • Under the age of 18 and over the age of 29
  • Unable to provide informed consent
  • Verbally or physically threatening to research staff

Treatment and study plan

PrEP messages

Behavioral

The peer leaders and the study staff will post PrEP related health messages

Heath messages

Behavioral

The peer leaders and study staff will post general health messages that are not related to sexual health

Primary outcomes

  1. PrEP uptake

    Time frame: PrEP uptake at baseline

    Actual PrEP uptake: participants self report if they use prep (Yes/No)

  2. PrEP uptake

    Time frame: PrEP uptake (Yes/No) at 24-weeks

    Actual PrEP uptake: participants self report if they use prep (Yes/No)

Secondary outcomes

  1. HIV testing

    Time frame: baseline

    Date of the last HIV test: participants self report the date of their last HIV test as a function of time in days.

  2. HIV testing

    Time frame: 24-weeks

    Date of the last HIV test: participants self report the date of their last HIV test as a function of time in days.

  3. PrEP use intention

    Time frame: PrEP use intention at baseline

    Willingness to use/likelihood of using PrEP in the next 6 months : self reported assessment to measure participants' willingness to use prep in the next 6 month s on a single question using Likert scale from 1(very unlikely) to 7 (very likely)

  4. PrEP use intention

    Time frame: PrEP use intention at 24-weeks

    Willingness to use/likelihood of using PrEP in the next 6 months : self reported assessment to measure participants' willingness to use prep in the next 6 month s on a single question using Likert scale from 1(very unlikely) to 7 (very likely)

  5. PrEP knowledge

    Time frame: PrEP knowledge at baseline

    Knowledge of PrEP for HIV prevention: self reported assessment to measure participants' knowledge on PrEP on a set of True or False questions

  6. PrEP knowledge

    Time frame: PrEP knowledge at 24-weeks

    Knowledge of PrEP for HIV prevention: self reported assessment to measure participants' knowledge on PrEP on a set of True or False questions

  7. self efficacy to use PrEP

    Time frame: self efficacy to use PrEP at baseline

    Beliefs in his/her ability of using PrEP: participants self report their level of confidence in taking PrEP on a set of items using Likert scales from 1 (Not at all confident) to 5 (completely confident)

  8. self efficacy to use PrEP

    Time frame: self efficacy to use PrEP at 24-weeks

    Beliefs in his/her ability of using PrEP: participants self report their level of confidence in taking PrEP on a set of items using Likert scales from 1 (Not at all confident) to 5 (completely confident)

  9. motivation to use PrEP

    Time frame: motivation to use PrEP at baseline

    How motivated s/he is to use PrEP and what motivates s/he to use PrEP: self reported assessment to measure participants' different types of motivation to use PrEP on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

  10. motivation to use PrEP

    Time frame: motivation to use PrEP at 24-weeks

    How motivated s/he is to use PrEP and what motivates s/he to use PrEP: self reported assessment to measure participants' different types of motivation to use PrEP on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

  11. PrEP stigma

    Time frame: PrEP stigma at baseline

    Perceived stigma related to PrEP use: self reported assessment to measure perception of stigma related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

  12. PrEP stigma

    Time frame: PrEP stigma at 24-weeks

    Perceived stigma related to PrEP use: self reported assessment to measure perception of stigma related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

  13. Social support for PrEP use

    Time frame: Social support for PrEP use at baseline

    Help and support that individuals receive that can facilitate PrEP uptake: Perceived stigma related to PrEP use: self reported assessment to measure perception of social support related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

  14. Social support for PrEP use

    Time frame: Social support for PrEP use at 24-weeks

    Help and support that individuals receive that can facilitate PrEP uptake: Perceived stigma related to PrEP use: self reported assessment to measure perception of social support related to PrEP use on a set of items using Likert scales from 1(strongly disagree) to 7 (strongly agree)

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Substance Abuse and Mental Health Services Administration (SAMHSA)

Registry information

Important dates

Study start
2018
Primary completion
2023
Study completion
2023
First posted
Jun 5, 2020
Registry last updated
Oct 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.